In squamous cell carcinomas (SCC), FAK localizes in the nucleus and promotes the transcription of chemokines that lead to the differentiation of T cells into T-reg, and thus, evasion of anti-tumor immunity [104,105]. Here, PTK2 is linked to neoplasm.